National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
National Institutes of Health is a biomedical research facility in the United States. It is affiliated with the United States Department of Health and Human Services. It is the primary agency of the United States government responsible for biomedical and health-related research. It conducts its own scientific research through its Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.National Institutes of Health has 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research. It comprises 27 separate institutes and centers that conduct research in different disciplines of biomedical science.With scientific accomplishments such as the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, the creation of vaccines against hepatitis, Haemophilus influenzae (HIB), and human papillomavirus, National Institutes of Health has many agencies under its control.National Institutes of Health was established in 1887. It is based in Bethesda, Maryland.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 15, 2017 | Grant | $5M | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 26, 2023
Medcognetics
|
Grant | $750K | Information Technology | Yes |
Jan 25, 2023
Oklahoma Medical Research Foundation
|
Grant | $3.40M | Biotechnology | Yes |
Jan 24, 2023
University of Pittsburgh
|
Grant | $11.20M | Education | Yes |
Jan 10, 2023
Florida International University
|
Grant | $3M | Education | Yes |
Dec 15, 2022
Albert Einstein College of Medicine
|
Grant | $5.20M | Education | Yes |
National Institutes of Health has had 69 exits. National Institutes of Health most notable exits include SolveBio , CardiaLen
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 24, 2023 | SolveBio | M&A | Biotechnology | Detail |
Dec 14, 2022 | CardiaLen | M&A | Biotechnology | Detail |
Jul 5, 2022 | DiscoveryBioMed | M&A | Biotechnology | Detail |
May 10, 2022 | Novosteo | M&A | Biotechnology | Detail |
Oct 25, 2021 | SAB Biotherapeutics | IPO | Biotechnology | Detail |